The relationship between biochemical failure and time to nadir in patients treated with external beam therapy for T1-T3 prostate carcinoma
- 1 August 1998
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 48 (2) , 203-207
- https://doi.org/10.1016/s0167-8140(98)00061-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer.Journal of Clinical Oncology, 1996
- Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate Cancer: The relationship between nadir level and disease-free survivalJournal of Urology, 1996
- Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.Journal of Clinical Oncology, 1995
- Three-Dimensional Conformal Radiation Therapy in Localized Carcinoma of The Prostate: Interim Report of A Phase 1 Dose-Escalation StudyJournal of Urology, 1994
- Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancerCancer, 1993
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972